Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neglected diseases: progress in drug development

Simon L Croft

    Current Opinion in Investigational Drugs (London, England : 2000)
    |March 3, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities.

    Parasites & vectors·2025
    Same author

    Comparative <i>in vitro</i> susceptibility of clinical <i>Leishmania</i> isolates to miltefosine and oleylphosphocholine.

    Frontiers in pharmacology·2025
    Same author

    Challenges in sustaining the elimination of visceral leishmaniasis in India.

    International health·2025
    Same author

    Comparative assessment of macrophage responses and antileishmanial efficacy in dynamic vs. Static culture systems utilizing chitosan-based formulations.

    PloS one·2025
    Same author

    Dermal microdialysis: A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL).

    Experimental parasitology·2023
    Same author

    Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis.

    The Journal of antimicrobial chemotherapy·2023
    Same journal

    Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?

    Current opinion in investigational drugs (London, England : 2000)·2011
    Same journal

    Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.

    Current opinion in investigational drugs (London, England : 2000)·2010
    Same journal

    Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.

    Current opinion in investigational drugs (London, England : 2000)·2010
    Same journal

    Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.

    Current opinion in investigational drugs (London, England : 2000)·2010
    Same journal

    Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.

    Current opinion in investigational drugs (London, England : 2000)·2010
    Same journal

    Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.

    Current opinion in investigational drugs (London, England : 2000)·2010
    See all related articles